Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on VALIRX PLC. We currently have 33 research reports from 3 professional analysts.
|02Dec16 04:15||RNS||Convertible Loan Facility|
|01Dec16 07:00||RNS||ValiSeek Clinical Development Update|
|29Nov16 07:00||RNS||Quarterly Update on Clinical Developments|
|03Nov16 07:00||RNS||ValiSeek Clinical Development Update|
|28Oct16 09:00||RNS||Corporate Video re Clinical Status Q4, 2016|
|25Oct16 07:00||RNS||Patent Update|
|13Oct16 04:20||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
02 Dec 16
"By late Sunday, we should have a good idea whether or not Italian Prime Minister, Matteo Renzi, will be stepping down. The polls suggest his constitutional referendum, which has effectively become a confidence vote on his premiership, will get a 'thumbs down'. No new election is actually required until February 2018, but any attempt to simply replace him with another technocrat leader could well see a public, suffering from implosion of their bad-debt laden banking system, 38% youth unemployment and an inability to stifle giant capital outflows, clamouring for a snap election. This, of course, would open the door for Bepe Grillo's Five Star Movement, whose denouncement of the Euro could, in turn, generate in a wave of similar populist referendum voting across other dissatisfied EU nations, with France's own presidential election, due to take place on 7th May, the headline this morning following Francois Hollande's overnight declaration that he has decided not to stand. The prospect of Eurozone's collapse, however, was not the driver of the US session, which started in the positive following release of strong November Manufacturing ISM data, but waned later as a sell-off amongst tech issues pushed the NASDAQ sharply down, while the Dow Jones managed to hold onto modest gains due to sustained switching into financials, as divergence between the two sectors and the rout in government bond markets since Trump's election continued. Asian shares were lower across the board, with the Nikkei suffering as the Yen found buyers amongst US$ sceptics waiting for flaws in the Trump rally to show through, which dragged the other regional markets with it. With investors now virtually taking a 25bp hike by the Fed later this month for granted, focus this afternoon is likely to centre on the important US employment report, with forecasts in the 180k to 200k range, taking unemployment to 4.8% with a modest rise in hourly earnings of around 0.1%. The UK will also report Construction PMI figures this morning while corporates due to disclose earnings or trading updates include 88 Energy (88E.L), Altona Energy (ANR.L) and Berkeley Group Holdings (BKG.L). Traders meanwhile continue to watch oil futures carefully; although prices moderated during the Asian session, sentiment following OPEC's agreement remains positive with January's light, sweet crude trading a whisker below US$51 on the Mercantile Exchange, as they weigh up expectations on the terms being upheld or the various participants instead deciding to cheat on quotas rather than give up market share to US shale producers. London equities opened in a nervous mood this morning, with the FTSE-100 down over 57 points in early trading." - Barry Gibb, Research Analyst
30 Nov 16
Oil is in focus today ahead of OPEC’s 171st ordinary meeting scheduled to open in Vienna at 11:00hrs local time, followed by the secretary-general holding a press conference at 16:00hrs. Crude prices weaken around 4% during yesterday’s European and US sessions, only to recover somewhat in the early hours of Wednesday after Iran and Iraq indicated a willingness to hold production levels steady as their contribution toward the Organisation’s proposal to trim output by 32.5m to 33.0m barrels per day. Still someway from Saudi Arabia’s own demand for a broadly-based cut in which all major contributors participate, and given that non-member, Russia, is expected to be absent, hopes of a successful outcome have faded somewhat. With Trump apparently set to appoint key supporter and Wall Street veteran, Steven Mnuchin, 53, as Treasury Secretary US equities rose fractionally across the board, with weakness in energy stocks, due to WTI plunging to a two-week low, compensated by a strong run in healthcare. Asia by comparison was mostly weaker, with only the US$-dominated Hang Seng remaining marginally positive, while the Shanghai Composite fell sharply away as traders again considered the potential impact of Trump’s proposed import tariffs on Chinese-made goods, as the Nikkei closed unchanged following marginally better October industrial output data and the ASX was pressured by a general sell-off amongst its oil stocks. Traders in Europe this morning will be examining the European Council President, Donald Tusk’s, response to a letter from UK MPs in which he stated that the EU cannot enter side-talks regarding the status if citizens until the UK actually triggers Article 50. This adds to the lack of Brexit transparency already fostered by Theresa May’s government and is considered to be behind the decline in GfK’s long-running consumer confidence index, which fell 5 points in November and now stand at 16 points below the level reached this time last year, albeit contrasting sharply with the positive UK mortgage data released yesterday which pushed the housebuilding sector up in the process. While OPEC takes centre stage, analysts will be pouring over the Bank of England’s stress test results this morning, with a particular focus on RBS as the most vulnerable of the majors, having factored in deep recessionary scenarios including a plunge in house prices, a halving of oil and a spike in unemployment. The FTSE is due to release its quarterly review and the Eurozone is also due to produce its flash inflation estimate. UK corporates expected to release earnings or trading updates include Biffa (BIFF.L), Brewin Dolphin (BRW.L), Britvic (BVIC.L), Greene King (GNK.L), RPC Group (RPC.L), Sage Group (SGE.L), Telford Homes (TEF.L) and Zoopla (ZPLA.L). The FTSE-100 is seen to be 5 points up in early trading.
N+1 Singer - Morning Song 05-12-2016
05 Dec 16
RTHM is acquiring a profitable Canadian listed mobile specialist for equivalent of US$42.5m consideration in shares (88.235m). This helps adds to two growth vectors RTHM is targeting; (i) adds unique exclusive audience (10m unique) and (ii) Exclusive demand Yahoo and Facebook. The business has 15 premium and owned and operated apps which provide users with rewards for activity. The business is expected to deliver c$9m of EBITDA in FY18 including $2m of cost synergies. This equates to just 4.7x EV/EBITDA. This marks what we see the first step in RTHM activity to scale the business and deliver on margin potential (see our initiation notes). Our initial estimates for EPS revisions are very significant - for FY18 are 2.3 cents (currently 0.6) and for FY19 4.3 (currently 2.5). There is a call at 830 for investors and we will revise post this.
Panmure Morning Note 02-12-16
02 Dec 16
We expect CareTech to report FY results to September on 8th December. A positive trading update in October indicated that performance for the year was in line with market expectations therefore we are focusing on the outlook. We expect a confident statement since the end of 2016 showed positive trends across fee rates, expansion in places and occupancy. We believe CareTech is well positioned for further expansion, and remains at an attractive valuation. We retain our BUY and 380p price target.
N+1 Singer - Morning Song 06-12-2016
06 Dec 16
With FY16 volume and revenue already disclosed in the pre-close, the focus in today’s prelims is on PBT (£100.3m versus our £101m) and EPS (96.8p versus our 95.4p). No special dividend triggered this year (none forecast) and DPS is held at 46.8p (N1SE: 48.0p). On end markets, recent commentary is reiterated – the core business is growing, whilst consumer electronics will be subdued in the current year (competitive capacity from Solvay). On currency, there will be a material benefit in the current year (a little more than the £14m to £15m previously indicated), and a further tailwind next year if current rates are maintained (quantum TBC). There is also an investment of £10m today in a minority interest in Magma Global, Victrex’ oil and gas mega programme partner. Although the share price is now close to our TP of 1730p, we feel that there is enough in today’s announcement to retain a positive stance on medium term opportunities with strong cashflow and a special dividend potentially to look forward to in the current year.
Panmure Morning Note 05-12-16
05 Dec 16
This week will see Chi-Med present data on both fruquintinib and epitinib at the 17th World Conference on Lung Cancer, concerning two proof-of-concept trials in non-small cell lung cancer (NSCLC). This morning, the poster presentation ‘A Phase I Study of Epitinib To Evaluate Efficacy And Safety In EGFR Mutation Positive (EGFRm+) NSCLC Patients With Brain Metastasis’ is available for investors to view on Chi-Med’s website.
Panmure Morning Note 01-12-16
01 Dec 16
Last month we highlighted the ongoing trajectory of Tuzistra sales, noting the impact of significant investment in the modified marketing strategy for Tuzistra, supported by the step up in sales personnel and increased marketing expenditure. This morning’s AGM statement and trading update gives some further colour on progress.